PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-31

  1. 5,194 Posts.
    lightbulb Created with Sketch. 671
    I hope they dont head in too many directions spending valuable time, money and focus and ending up jack of all trades, master of none.. This drug could possibly be used for dozens of medical ailments so i just hope OA doesnt get put to the side if they come up with other uses for PPS. Hopefully they have a clear path of where they are going with this drug.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.